Cronos Group (NASDAQ:CRON) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Cronos Group (NASDAQ:CRON - Get Free Report) released its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.01, Zacks reports. Cronos Group had a negative return on equity of 2.56% and a negative net margin of 42.65%. The business had revenue of $33.62 million during the quarter, compared to the consensus estimate of $45.44 million.

Cronos Group Stock Down 0.7%

Shares of CRON traded down $0.02 during trading hours on Thursday, hitting $2.05. The company had a trading volume of 416,394 shares, compared to its average volume of 1,324,564. Cronos Group has a 52-week low of $1.60 and a 52-week high of $3.14. The firm has a market cap of $788.16 million, a P/E ratio of -15.73, a P/E/G ratio of 1.74 and a beta of 1.06. The stock's 50 day moving average price is $1.82 and its 200 day moving average price is $1.94.

Cronos Group Company Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.